Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • Health Equity through Her Lens
    • The Health Equity podcast
    • Access insights
    • Health Equity through Her Lens
    • The Health Equity podcast
  • News
  • Our team
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

The Investor’s role in the fight against AMR: Investing responsibly to maximise impact

In partnership with the World Health Organization (WHO), the Access to Medicine Foundation will host a live webinar in recognition of World AMR Awareness Week (WAAW) 2025. The one-hour session will centre around the threat of AMR to the global economy, narrowing in on the role investors can play in helping to curb the impact.

Date

20 November 2025

Direct links

Register for the webinar

DATE

Thursday, 20 November 2025

TIME

12:00-13:00 CET

FORMAT

Virtual. Register to attend here.

Antimicrobial resistance (AMR) is not only a threat to public health, with millions of deaths from drug-resistant infections occurring each year, but also to the stability of the global economy. The complexity and cost of care associated with drug-resistant infections contributes to trillions of dollars in annual GDP losses, and the impact is only expected to grow. 

Following last year’s High-Level Meeting on AMR at the United Nations General Assembly, which underlined the importance of cross-sector collaboration in addressing the crisis, it is clear that the collective response is still too fragmented and a more coordinated effort is needed. 

Investors are increasingly recognising AMR as both a material financial risk and a critical sustainability priority. By leveraging their influence on the pharmaceutical industry, they have the power to drive company accountability and help reinforce global commitments that will lead to real progress in the fight against AMR. 

About the webinar 

In partnership with the World Health Organization (WHO), the Foundation is hosting a live webinar entitled ‘The Investor’s role in the fight against AMR: Investing responsibly to maximise impact.’ The session will cover: 

  • AMR’s implications for market resilience and long-term investment returns 

  • How pharmaceutical companies are addressing AMR, including best practices and ongoing initiatives 

  • Areas where more action is needed and how investors can accelerate company action within those areas 

  • Practical solutions and accountability mechanisms that can be used to evaluate companies’ performance on AMR and ensure commitments turn into measurable impact 

Moderator

  • Claudia Martínez, Director of Research, Access to Medicine Foundation 

Opening remarks

  • Yvan J.-F. Hutin, Director, AMR Department, Health Systems Division, WHO 

Panelists

  • Valeria Gigante, Team Lead, AMR Department, WHO 

More to be announced 

Register for the webinar 

To join this live event, please follow this link to register your attendance.  

For insights from last year's webinar, watch the video below

Webinar: Mobilising pharma to act on the AMR Political Declaration

Watch the video

Divya Verma

Head of Communications

dverma@accesstomedicinefoundation.org

Get in touch

Research Hub

Explore our research reports and publications
Research

The methodology for the 2026 AMR Benchmark

28 January 2025
Research

Health & Wealth: The Investors’ Guide to Antimicrobial Resistance (AMR), a Growing Global Health Crisis

27 August 2024
Research

How can pharma get the few promising drugs in development to patients battling superbugs?

23 May 2024

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved